首页> 外文期刊>Journal of Clinical Pathology >Potential role of leptin expression in hepatocellular carcinoma.
【24h】

Potential role of leptin expression in hepatocellular carcinoma.

机译:瘦素表达在肝细胞癌中的潜在作用。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Obesity is associated with hepatocellular carcinoma (HCC). The association may result from the aberrant expression of adipokines. AIM: To explore the potential biological effect and prognostic value of leptin, one of the adipokines, in HCC. METHODS: Immunohistochemistry was used to evaluate the expression of leptin in 68 patients with HCC. The expression of Ki-67 and microvessel density (MVD) of tumorous lesions in HCC were also analysed. The result of leptin expression was further correlated with Ki-67 expression, intratumour MVD, clinicopathological characteristics, overall survival and the postoperative use of medroxyprogesterone acetate (MPA). RESULTS: High leptin expression was seen in 60.3% of patients with HCC and was significantly correlated with intratumour MVD (high v low; 59.2 (standard deviation 3.2) v 44.2 (19.5), p = 0.004), but not with Ki-67 expression. No marked correlation was seen between leptin expression and clinicopathological characteristics. However, using a multivariate Cox's proportional hazards model, leptin expression was a predictor for improved overall survival of patients with HCC (odds ratio 0.16; 95% confidence interval 0.03 to 0.87; p = 0.033). In addition, the Kaplan-Meier survival curve showed that high leptin expression was associated with a better survival in patients with HCC, treated postoperatively with MPA (p = 0.008, log rank test). CONCLUSION: High leptin expression was associated with an increased intratumour MVD and thus may be associated with HCC development. In addition, high leptin expression was a predictor for improved survival of patients with HCC, treated postoperatively with MPA.
机译:背景:肥胖与肝细胞癌(HCC)有关。这种联系可能是由于脂肪因子表达异常引起的。目的:探讨瘦素(一种脂肪因子)在肝癌中的潜在生物学效应和预后价值。方法:采用免疫组织化学方法检测68例肝癌患者瘦素的表达。还分析了肝癌中Ki-67的表达和肿瘤病变的微血管密度(MVD)。瘦素表达的结果与Ki-67表达,肿瘤内MVD,临床病理特征,总体生存率以及醋酸甲羟孕酮(MPA)的术后使用进一步相关。结果:60.3%的HCC患者中观察到瘦素高表达,并且与肿瘤内MVD显着相关(高v低; 59.2(标准偏差3.2)v 44.2(19.5),p = 0.004),但与Ki-67表达无关。瘦素表达与临床病理特征之间没有明显的相关性。但是,使用多变量Cox比例风险模型,瘦素表达是肝癌患者整体生存改善的预测指标(优势比0.16; 95%置信区间0.03至0.87; p = 0.033)。此外,Kaplan-Meier生存曲线表明,瘦素的高表达与MPA术后HCC患者的更好生存相关(p = 0.008,对数秩检验)。结论:瘦素高表达与肿瘤内MVD增加有关,因此可能与肝癌的发生有关。此外,瘦素高表达是术后MPA治疗可提高HCC患者生存率的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号